Biobanking in Times of COVID-19, Pre-analytical Procedures

Routine processing of COVID-19 samples from the bedside to the laboratory and to the biobank will be addressed, and we will discuss whether researchers have any additional requirements for the sample quality, when thinking of any scientifically driven downstream analysis. Together with Lukasz Kozera, colleagues and partners from the biobanking community, I will address your questions and together we will try to give answers while incorporating your expertise.